Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mostafa Norizadeh Tazehkand & Mehmet Topaktas. (2015) The in vitro genotoxic and cytotoxic effects of remeron on human peripheral blood lymphocytes. Drug and Chemical Toxicology 38:3, pages 266-271.
Read now
Read now
Articles from other publishers (30)
Emad H. M. Hassanein, Hanan S. Althagafy, Mohammad A. Baraka, Esraa K. Abd-alhameed & Islam M. Ibrahim. (2023) Pharmacological update of mirtazapine: a narrative literature review. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Miloš N. Milosavljević, Slobodan M. Janković, Marina J. Kostić & Ana V. Pejčić. (2023) Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review. Journal of Psychiatric Practice 29:1, pages 58-70.
Crossref
Crossref
Gernot Fugger, Lucie Bartova, Chiara Fabbri, Giuseppe Fanelli, Raffaella Zanardi, Markus Dold, Alexander Kautzky, Dan Rujescu, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery, Alessandro Serretti & Siegfried Kasper. (2022) The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs. Journal of Affective Disorders 312, pages 225-234.
Crossref
Crossref
Haihua Tian, Zhenyu Hu, Jia Xu & Chuang Wang. (2022) The molecular pathophysiology of depression and the new therapeutics. MedComm 3:3.
Crossref
Crossref
Xiaohui Wu, Yuncheng Zhu, Zhiguo Wu, Jia Huang, Lan Cao, Yun Wang, Yousong Su, Hongmei Liu, Maosheng Fang, Zhijian Yao, Zuowei Wang, Fan Wang, Yong Wang, Daihui Peng, Jun Chen & Yiru Fang. (2022) Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis. Frontiers in Psychiatry 13.
Crossref
Crossref
Viacheslav Terevnikov & Grigori Joffe. (2022) Mirtazapine in schizophrenia – an undeservedly overlooked option?. International Clinical Psychopharmacology 37:4, pages 131-142.
Crossref
Crossref
Anne Ostenfeld, Tonny Studsgaard Petersen, Lars Henning Pedersen, Hanne Brix Westergaard, Ellen Christine Leth Løkkegaard & Jon Trærup Andersen. (2022) Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study. Acta Psychiatrica Scandinavica 145:6, pages 557-567.
Crossref
Crossref
Kyu-Man Han. (2022) Pharmacotherapy for late-life depression. Journal of the Korean Medical Association 65:3, pages 176-184.
Crossref
Crossref
Yohei Kawano, Maki Obana, Masashi Nagata, Yasunari Mano, Maho Katsuyama, Yuichiro Yamamoto, Ayako Maeda-Minami, Kenichi Negishi, Masamichi Takagi, Shuji Shimada & Takao Aoyama. (2022) The antiplatelet effect of mirtazapine is mediated by co-blocking 5-HT2A and α2-adrenergic receptors on platelets: An in vitro human plasma-based study. European Journal of Pharmacology 917, pages 174640.
Crossref
Crossref
Alireza Khalilian, Davoud Ahmadimoghaddam, Shiva Saki, Younes Mohammadi & Maryam Mehrpooya. (2021) A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome. BioPsychoSocial Medicine 15:1.
Crossref
Crossref
Alexei Verkhratsky, Vladimir Parpura, Caterina Scuderi & Baoman Li. 2021. Astrocytes in Psychiatric Disorders. Astrocytes in Psychiatric Disorders
317
347
.
Joseph SadekJoseph Sadek. 2021. Clinician’s Guide to Psychopharmacology. Clinician’s Guide to Psychopharmacology
17
57
.
Rachelle Paige Davis, Wagdi Almishri, Craig Neal Jenne & Mark Gordon Swain. (2020) The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice. Frontiers in Immunology 11.
Crossref
Crossref
Anne Ostenfeld, Tonny Studsgaard Petersen, Tina Bergmann Futtrup, Jon Trærup Andersen, Andreas Kryger Jensen, Hanne Brix Westergaard, Lars Henning Pedersen & Ellen Christine Leth Løkkegaard. (2020) Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial. BMJ Open 10:3, pages e034712.
Crossref
Crossref
JamirPitton Rissardo & AnaLeticia Fornari Caprara. (2020) Mirtazapine-associated movement disorders: A literature review. Tzu Chi Medical Journal 32:4, pages 318.
Crossref
Crossref
Kazue Hisaoka-Nakashima, Sayaka Taki, Shintaro Watanabe, Yoki Nakamura, Yoshihiro Nakata & Norimitsu Morioka. (2019) Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes. European Journal of Pharmacology 860, pages 172539.
Crossref
Crossref
Wagdi Almishri, Abdel Aziz Shaheen, Keith A. Sharkey & Mark G. Swain. (2019) The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice. Frontiers in Immunology 10.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, Federica Vellante, Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Laura Orsolini, Carmine Tomasetti, Gabriella Di Emidio, Giovanni Martinotti & Massimo Di Giannantonio. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
349
367
.
Blanca Perez-Palomar, Irene Mollinedo-Gajate, Esther Berrocoso, J. Javier Meana & Jorge E. Ortega. (2018) Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram. Neuropharmacology 133, pages 491-502.
Crossref
Crossref
Eberhard Schlicker & Thomas Feuerstein. (2017) Human presynaptic receptors. Pharmacology & Therapeutics 172, pages 1-21.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Canan TanıdırSabri Hergüner. (2015) Mirtazapine for Choking Phobia: Report of a Pediatric Case. Journal of Child and Adolescent Psychopharmacology 25:8, pages 659-660.
Crossref
Crossref
Hoo Rim Song, Won-Myong Bahk, Young Sup Woo, Jong-Hyun Jeong, Young-Joon Kwon, Jeong Seok Seo, Won Kim, Moon-Doo Kim, Young-Chul Shin, Sang-Yeol Lee & Kyung Joon Min. (2015) Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study. Clinical Psychopharmacology and Neuroscience 13:2, pages 144-149.
Crossref
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
e1
e96
.
Matej Stuhec, Joseph Alisky & Ivan Malesic. (2014) Mirtazapine Associated With Drug-Related Thrombocytopenia. Journal of Clinical Psychopharmacology 34:5, pages 662-664.
Crossref
Crossref
Tamaki Ishima, Yuko Fujita & Kenji Hashimoto. (2014) Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. European Journal of Pharmacology 727, pages 167-173.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Li‐Min Sun, Ming‐Chia Lin, Ji‐An Liang, Yen‐Jung Chang, Shih‐Ni Chang, Fung‐Chang Sung, Chih‐Hsin Muo & Chia‐Hung Kao. (2013) Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?. Pharmacoepidemiology and Drug Safety 22:12, pages 1292-1297.
Crossref
Crossref
Ole L Munk & Donald F Smith. (2011) PET kinetics of radiolabeled antidepressant, [N-methyl-11C]mirtazapine, in the human brain. EJNMMI Research 1:1, pages 36.
Crossref
Crossref